Cannabis use was not linked to longitudinal cognitive decline or dementia risk. Within the limits of these cohorts, we found no evidence that cannabis use contributes substantially to cognitive ageing or dementia risk in older adults.
Full article: Behaviors Related to Medical Cannabis Use in Older Adults: A Qualitative Study
✦ New CED Clinical Relevance #86High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic GeriatricsPatient BehaviorPolypharmacyDrug InteractionsClinical Practice Why This MattersOlder adults represent the fastest-growing demographic of...
New side effect from smoking cannabis discovered in groundbreaking study – LADbible
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingSafety Why This Matters This finding is clinically significant because it expands understanding of cannabis...
Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients
Medical cannabis counseling for older adults is becoming more important as more seniors ask clinicians about cannabis for pain, sleep, and anxiety. This study shows that many physicians are having these conversations, but most still do not feel fully prepared to give detailed, age-specific guidance. For patients and providers alike, the message is clear: interest is rising faster than clinical education.
Cannabinoids Appear Generally Safe in Adults Over 50, But Evidence Is Limited and Heterogeneous
Although cannabinoid-based medications were generally safe and acceptable to adults aged over 50 years, these estimates are limited by the lack of a control condition and considerable heterogeneity. Nevertheless, they complement and are consistent with comparable evidence from randomised controlled trials.
Medical Cannabis in Older Adults: Promising Interest, Thin Evidence
Evidence of efficacy for relief of an array of symptoms is overall scanty, and almost all study participants are aged < 60 years. The risk of known and potential adverse effects is considerable, with concerns for cognitive, cardiovascular and gait and stability effects in older adults.
Older Adults on Medical Cannabis Face Doubled Intoxication Risk When Co-Prescribed Narrow Therapeutic Index Drugs
The risk of drug-related intoxication was 2.61 (95% CI 1.42–4.79) amongst 3,926 patients exposed to cannabis and DNTI compared to 12,223 controls.
Common But Manageable: What a 58-Trial Meta-Analysis Reveals About Cannabis Medicine Side Effects in Older Adults
Although CBMs in general are safe and acceptable in middle aged and older adults, one needs to be mindful of certain common dose-dependent side-effects of THC-containing CBMs.
Older Adults Report Pain, Sleep, and Mood Benefits from Medical Cannabis — But the Evidence Has Major Gaps
Among older adults, medical cannabis is used more often by women, with CBD-containing cannabis oils being the most commonly used. Users reported improved pain, sleep, and mood symptoms at follow-up — though without a control group, these self-reported changes cannot be causally attributed to cannabis.
Cannabis Medicines Appear Broadly Tolerated in Adults Over 50, But Key Uncertainties Remain
Although cannabinoid-based medications were generally safe and acceptable to adults aged over 50 years, these estimates are limited by the lack of a control condition and considerable heterogeneity. Nevertheless, they complement and are consistent with comparable evidence from randomised controlled trials.